Luminance and chromatic visual evoked potentials in type I and type II diabetes: relationships with peripheral neuropathy
- PMID: 17122941
- DOI: 10.1007/s10072-006-0704-x
Luminance and chromatic visual evoked potentials in type I and type II diabetes: relationships with peripheral neuropathy
Abstract
The objective of the study was to investigate the subclinical visual deficit in type I and II diabetes, and its relationship with peripheral neuropathy. Thirty-two healthy volunteers, 20 patients with type I diabetes and 30 patients with type II diabetes were studied in a clinical neurophysiology setting. Luminance (VEPs) and chromatic visual evoked potentials (CVEPs) were recorded, with white-black, grey-black, red-green and blue-yellow sinusoidal gratings. The peak latencies of the VEP positive wave and CVEP negative wave were recorded. Ten patients with type I and 8 with type II diabetes had peripheral neuropathy. VEPs were slower in patients with type II diabetes and CVEPs were slower in patients with type I and type II diabetes than in controls. Blue-yellow CVEPs were slower in type II than in type I diabetes. VEPs and red-green CVEPs were slower in patients with diabetes with neuropathy than in those without. In conclusion, we found that visual system impairment differs in diabetes with and without peripheral neuropathy.
Comment in
-
Visual evoked potentials and diabetic polyneuropathy.Neurol Sci. 2006 Nov;27(5):299-300. doi: 10.1007/s10072-006-0699-3. Neurol Sci. 2006. PMID: 17122936 No abstract available.
Similar articles
-
Chromatic modulation of luminance visual evoked potential latencies in healthy subjects and patients with mild vision disorders.Clin Neurophysiol. 2008 Jul;119(7):1683-8. doi: 10.1016/j.clinph.2008.03.011. Epub 2008 May 1. Clin Neurophysiol. 2008. PMID: 18455475
-
Visual evoked potentials for reversals of red-green gratings with different chromatic contrasts: asymmetries with respect to isoluminance.Vis Neurosci. 2005 Nov-Dec;22(6):749-58. doi: 10.1017/S0952523805226068. Vis Neurosci. 2005. PMID: 16469185 Clinical Trial.
-
Evaluation of central neuropathy in type II diabetes mellitus by multimodal evoked potentials.Acta Neurol Belg. 2003 Dec;103(4):206-11. Acta Neurol Belg. 2003. PMID: 15008505
-
Chromatic visual evoked potentials: A review of physiology, methods and clinical applications.Prog Retin Eye Res. 2024 Jul;101:101272. doi: 10.1016/j.preteyeres.2024.101272. Epub 2024 May 16. Prog Retin Eye Res. 2024. PMID: 38761874 Review.
-
Evoked potentials in diabetes mellitus.Clin Neurosci. 1997;4(6):374-9. Clin Neurosci. 1997. PMID: 9358983 Review.
Cited by
-
Evaluation of visual pathways using visual evoked potential in patients with diabetic retinopathy.Rom J Ophthalmol. 2019 Oct-Dec;63(4):367-371. Rom J Ophthalmol. 2019. PMID: 31915735 Free PMC article.
-
Chromatic visual evoked potentials identify optic nerve dysfunction in patients with Graves' orbitopathy.Int Ophthalmol. 2022 Dec;42(12):3713-3724. doi: 10.1007/s10792-022-02369-4. Epub 2022 May 30. Int Ophthalmol. 2022. PMID: 35635597
-
The Single Administration of a Chromophore Alleviates Neural Defects in Diabetic Retinopathy.Am J Pathol. 2020 Jul;190(7):1505-1512. doi: 10.1016/j.ajpath.2020.03.009. Epub 2020 Apr 8. Am J Pathol. 2020. PMID: 32275905 Free PMC article.
-
Effect of sodium tungstate on visual evoked potentials in diabetic rats.Int J Ophthalmol. 2016 May 18;9(5):677-81. doi: 10.18240/ijo.2016.05.06. eCollection 2016. Int J Ophthalmol. 2016. PMID: 27275420 Free PMC article.
-
Association of nerve conduction impairment and insulin resistance in children with obesity.Childs Nerv Syst. 2016 Nov;32(11):2219-2224. doi: 10.1007/s00381-016-3210-3. Epub 2016 Aug 9. Childs Nerv Syst. 2016. PMID: 27503137
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical